Personalized Medicine in Cancer Treatment
When you or a loved one is diagnosed with cancer, receiving care that is tailored to your individual needs is crucial to achieving the best
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
If you or a loved one has been diagnosed with cancer, doctors can choose from many treatments to provide the best care possible for each patient’s unique needs. One of these treatments, immunotherapy, can be used in a variety of ways, and ongoing advancements make it an ideal choice for several types of cancer. Learn more about the basics of immunotherapy from Regional Cancer Care Associates, and schedule a consultation today to see if this treatment is appropriate for you.
Also known as biologic therapy, immunotherapy refers to medications that enhance the immune system’s natural response to battling cancer cells. Cancer cells disguise themselves from the immune system and prevent it from attacking them, but immunotherapy counteracts this process by helping the immune system better identify and eliminate these cells. This treatment also has been linked to success in preventing the spread of cancer to other areas of the body, as well as slowing or stopping cancer progression.
Generally, immunotherapy is accomplished in one of two ways. One technique stimulates the patient’s immune system into more effectively targeting and attacking cancer cells. This type of immunotherapy can involve:
The second method involves laboratory-produced or modified proteins that are injected into the immune system. This triggers a stronger response to cancer cells and trains the immune system to recognize and eliminate these cells. This version of immunotherapy may include:
To date, patients with specific types of cancer – including lymphoma, leukemia and prostate, skin, lung and kidney cancers – have responded well to different immunotherapies. There is also great hope that immunotherapy will demonstrate success in ongoing clinical trials in treating even more types of cancer, and that its benefits will extend to more patients over time.
One of the most promising advances in immunotherapy research involves tumor-agnostic treatments, also known as tissue-agnostic therapies. This involves drugs that can treat any type of cancer in any area of the body by targeting the cancer cells and forcing genetic changes. One medication that does this has been successful in targeting metastatic tumors or cancer that surgery cannot treat, generating high hopes in the medical community.
Our team of experts at Regional Cancer Care Associates administers immunotherapy to patients on a daily basis. Some types are effective on their own, while others are combined with additional forms of treatment for the best possible outcome. As mentioned above, some types of immunotherapy are better suited for specific forms of cancer – something your doctor will help you navigate while planning treatment.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
When you or a loved one is diagnosed with cancer, receiving care that is tailored to your individual needs is crucial to achieving the best
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different conditions can be managed and
Immunotherapy is an advanced type of cancer treatment. Instead of surgical procedures or radiation therapy, it works alongside the body’s natural immune system to fight
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.